Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Return on Assets (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Return on Assets for 6 consecutive years, with 2.53% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 122.0% to 2.53% in Q3 2025 year-over-year; TTM through Sep 2025 was 2.53%, a 122.0% decrease, with the full-year FY2024 number at 1.93%, up 65.0% from a year prior.
  • Return on Assets was 2.53% for Q3 2025 at Ensysce Biosciences, down from 1.31% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.45% in Q2 2021 to a low of 4.47% in Q1 2023.
  • A 5-year average of 2.28% and a median of 2.48% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: plummeted -273bps in 2023, then skyrocketed 267bps in 2024.
  • Ensysce Biosciences' Return on Assets stood at 1.69% in 2021, then tumbled by -102bps to 3.41% in 2022, then fell by -10bps to 3.74% in 2023, then soared by 71bps to 1.07% in 2024, then crashed by -136bps to 2.53% in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Return on Assets are 2.53% (Q3 2025), 1.31% (Q2 2025), and 1.35% (Q1 2025).